迈威生物(688062.SH)重新向香港联交所递交H股发行上市申请并刊发申请资料

Core Viewpoint - The company, Maiwei Biotech (688062.SH), has submitted an application for issuing H-shares and listing on the Hong Kong Stock Exchange on August 29, 2025 [1] Group 1 - The application was submitted to the Hong Kong Stock Exchange and the relevant materials were published on the same day [1] - The application materials were prepared in accordance with the requirements of the Hong Kong Securities and Futures Commission and the Hong Kong Stock Exchange [1] - The published materials are in draft form and may be updated or revised as necessary [1]